The nanoparticulation technology of Bio-Synectics can be a valuable tool to optimize the bioavailability of poorly soluble new drug candidates. It may also enable parenteral drug formulations minimizing the usage of harmful excipients.
We have been acquiring the patents of our platform technologies in major pharmaceutical markets worldwide. In case our technology is used in the reformulation of a marked drug for better efficacy, safety, or patient convenience, the platform patents will work as a strong strategical measure for the life cycle management of the drug product.
The initial stage collaboration of service agreement can be continued to a co-development and licensing agreement targeting the development of commercial nanoparticulate formulation of the drug product. It will take longer time frame and more dedicated effort of us and our partners. We will do our best to maximize the value added as the output of utilizing our nanoparticulation technology.